Search results for "CD34"

showing 10 items of 148 documents

Hematopoietic peripheral circulating blood stem cells as an independent marker of good transfusion management in patients with β-thalassemia: results…

2016

Background Beyond hemoglobin (Hb) levels and performance status, further surrogate markers of appropriate transfusion management should improve the quality of thalassemia care. We investigated the levels of peripheral circulating CD34+ stem cells as an independent marker of appropriate hematopoietic balance in patients with thalassemia. Study design and methods Peripheral circulating CD34+ stem cells, colony-forming unitgranulocyte, erythrocyte, macrophage, magakaryocyte (CF-GEMM), colony-forming unitgranulocyte/macrophage (CFU-GM), and erythroidburst-forming units (BFU-E) were assayed, according to standard procedures. Patients with thalassemia major (TM) and thalassemia intermedia (TI) we…

0301 basic medicinemedicine.medical_specialtyThalassemiamedicine.medical_treatmentImmunologyCD34Hematopoietic stem cell transplantationGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinemedicineImmunology and Allergybusiness.industryBeta thalassemiaHematologymedicine.diseaseRed blood cellHaematopoiesis030104 developmental biologymedicine.anatomical_structureImmunologyHemoglobinStem cellbusiness030215 immunologyTransfusion
researchProduct

Organotypic Epigenetic Signature Predicts Bone and Marrow Niche Forming Capacity of Stromal Progenitors in a Novel Mouse Model in Vivo.

2012

Abstract Abstract 2987 Mesenchymal stem/progenitor cells (MSPCs) from numerous tissues are currently tested in clinical trials despite a limited understanding of their in vivo behavior. In this study we used MSPCs from adult and fetal tissues to select the appropriate source for clinical application. We asked whether MSPCs derived from human bone marrow (BM), white adipose tissue (WAT) and umbilical cord (UC), compared to skin fibroblasts, bear an equivalent bone and marrow niche formation potential with of in vivo. Furthermore we evaluated attraction and engraftment of murine as well as human hematopoietic stem/progenitor cells (HSPCs) into newly formed MSPC-derived niches. To elucidate po…

0303 health sciencesPathologymedicine.medical_specialtyStromal cellImmunologyMesenchymal stem cellCD34Cell BiologyHematologyBiologyBiochemistryTransplantation03 medical and health sciencesHaematopoiesis0302 clinical medicinemedicine.anatomical_structuremedicineCancer researchBone marrowProgenitor cellStem cell030304 developmental biology030215 immunologyBlood
researchProduct

Myeloid sarcoma of the oral cavity : a case report and review of 89 cases from the literature

2017

Myeloid sarcoma is a tumor mass of immature myeloid or granulocytic cells that affects extramedullary anatomic sites, including uncommonly the oral cavity. A 24-year-old female was referred for evaluation of a fast growing painful gingival swelling lasting 2 weeks, associated with fever, fatigue, and cervical lymphadenopathy. Intraoral examination showed a bluish swelling on the right posterior lower gingiva exhibiting necrotic surface. Incisional biopsy of the gingival lesion displayed diffuse infiltration of undifferentiated tumor cells with granulocytic appearance, strongly immunopositive for CD99, myeloperoxidase and Ki-67 (60%), and negative for CD20, CD3, CD34 and TdT. Blood tests pre…

Acute promyelocytic leukemiaPathologymedicine.medical_specialtyMyeloidOral Medicine and Pathologybusiness.industryCD99CD34Myeloid leukemiaCase Report030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Pancytopenia03 medical and health sciences0302 clinical medicinemedicine.anatomical_structure030220 oncology & carcinogenesishemic and lymphatic diseasesUNESCO::CIENCIAS MÉDICASMyeloid sarcomaMedicineSarcomabusinessGeneral Dentistry
researchProduct

New insights into the cellular makeup and progenitor potential of palatal connective tissues

2017

The present study investigated the regenerative potential of connective tissues harvested from two palatal areas widely used as donor sites for muco-gingival surgical approaches. Connective tissue grafts (CTGs) were obtained by de-epithelialisation of a free gingival graft (deCTG) and by a split flap approach from a previous donor site (reCTG). Two types of mesenchymal stem cell (MSCs) were isolated and were named de-epithelialised MSCs (deMSCs) and re-entry MSCs (reMSCs). The cells were characterised and cellular functionality was investigated. CTGs were evaluated using immunohistochemical and ultrastructural approaches. No significant differences were observed regarding the frequency of c…

Adult0301 basic medicinePathologymedicine.medical_specialtyHistologyStromal cellCellular differentiationGingivaCD34Connective tissueAntigens CD34BiologyCell LineImmunophenotyping03 medical and health sciences0302 clinical medicineCell MovementOsteogenesismedicineHumansRegenerationProgenitor cellAutograftsInstrumentationConnective Tissue CellsLamina propriaAdipogenesisMucous MembranePalateStem CellsMesenchymal stem cellCell DifferentiationMesenchymal Stem Cells030206 dentistryPlatelet Endothelial Cell Adhesion Molecule-1Medical Laboratory TechnologyHyaluronan Receptors030104 developmental biologymedicine.anatomical_structureConnective TissueFemaleAnatomyStem cellChondrogenesisMicroscopy Research and Technique
researchProduct

Value of bone marrow biopsy in the diagnosis of essential thrombocythemia.

2004

Background and Objectives. Essential thrombocythemia (ET) is a Philadelphia chromosome-negative chronic myeloproliferative disorder (CMPD) whose diagnosis, according to the Polycythemia Vera Study Group (PVSG) criteria, does not include histopathological data. The new WHO classification of CMPD has supplied new diagnostic guidelines which highlight the value of histopathology and facilitate a more precise differentiation of ET from reactive conditions and other CMPD. Design and Methods. Bone marrow biopsies from 142 adult patients diagnosed with ET according to PVSG criteria were evaluated using the new WHO classification. Megakaryocyte morphology and arrangement, amount of fibrosis and a c…

AdultAged 80 and overAge DistributionAntigens CDBone MarrowBiopsyHumansReproducibility of ResultsAntigens CD34Mast Cell microenvironment angioimmunoblasticMiddle AgedAgedThrombocythemia Essential
researchProduct

Advanced Platelet-Rich Fibrin: A New Concept for Cell-Based Tissue Engineering by Means of Inflammatory Cells

2014

Choukroun's platelet-rich fibrin (PRF) is obtained from blood without adding anticoagulants. In this study, protocols for standard platelet-rich fibrin (S-PRF) (2700 rpm, 12 minutes) and advanced platelet-rich fibrin (A-PRF) (1500 rpm, 14 minutes) were compared to establish by histological cell detection and histomorphometrical measurement of cell distribution the effects of the centrifugal force (speed and time) on the distribution of cells relevant for wound healing and tissue regeneration. Immunohistochemistry for monocytes, T and B -lymphocytes, neutrophilic granulocytes, CD34-positive stem cells, and platelets was performed on clots produced from four different human donors. Platelets …

AdultBlood PlateletsPathologymedicine.medical_specialtyBone RegenerationErythrocytesTime FactorsAdolescentNeutrophilsT-LymphocytesAntigens CD34CentrifugationInflammationCell SeparationMonocytesFibrinYoung AdultTissue engineeringmedicineHumansRegenerationPlateletB-LymphocytesFibrinTissue Engineeringbiologybusiness.industryMacrophagesStem CellsCell DifferentiationMiddle AgedImmunohistochemistrydigestive system diseasesPlatelet-rich fibrinBlood Buffy Coatbiology.proteinOral Surgerymedicine.symptombusinessCell basedJournal of Oral Implantology
researchProduct

Sequential analysis of CD34+ and CD34− cell subsets in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCF plu…

2001

Administration of stem cell factor (SCF) has been proven to enhance cytokine-induced mobilization of CD34+ hematopoietic progenitor cells (HPC) into the peripheral blood (PB). The aim of the present study was to explore in a homogeneous group of 22 uniformly treated breast cancer patients: (1) the kinetics of mobilization into PB of both CD34+ and CD34- cell subsets, including dendritic cells, in sequential samples obtained from day +7 up to day +12 after mobilization; and (2) the composition of the CD34+ and CD34- cell subsets present in the two leukapheresis products obtained for each patient. The following CD34+ and CD34- subsets were analyzed: early CD34+ HPC, erythroid-, myeloid- and B…

AdultCancer ResearchAdolescentCD14CD34Antigens CD34Breast NeoplasmsStem cell factorBiologyImmunophenotypingGranulocyte Colony-Stimulating FactorHumansLeukapheresisAntigen-presenting cellCyclophosphamideHematopoietic Stem Cell MobilizationAgedStem Cell FactorHematologyDendritic cellLeukapheresisMiddle AgedMolecular biologyHematopoietic Stem Cell MobilizationRecombinant ProteinsGranulocyte colony-stimulating factorOncologyImmunologyFemaleLeukemia
researchProduct

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells.

2000

Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that can be used for vaccination purposes, to induce a specific T-cell response in vivo against melanoma-associated antigens. We have shown that the sequential use of early-acting hematopoietic growth factors, stem cell factor, IL-3 and IL-6, followed by differentiation with IL-4 and granulocyte-macrophage colony-stimulating factor allows the in vitro generation of large numbers of immature DCs from CD34(+) peripheral blood progenitor cells. Maturation to interdigitating DCs could specifically be induced within 24 hr by addition of TNF-alpha. Here, we report on a phase I clinical vaccination trial in melanoma patients us…

AdultCytotoxicity ImmunologicMaleCancer ResearchAdolescentmedicine.medical_treatmentCD34Antigens CD34Pilot ProjectsCancer VaccinesImmunotherapy AdoptiveImmune systemAntigenAntigens NeoplasmmedicineHumansCytotoxic T cellProgenitor cellMelanomaAgedAntigen Presentationbusiness.industryCell DifferentiationDendritic CellsImmunotherapyDendritic cellMiddle AgedHematopoietic Stem CellsHaematopoiesisOncologyImmunologyFemalePeptidesbusiness
researchProduct

Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients.

2007

Myeloid sarcoma ( MS) is a rare neoplasm whose knowledge is largely based on case reports and/or technically dated contributions. Ninety-two MSs in adulthood with clinical data available were evaluated both morphologically and immunohistochemically. Seventy-four cases were also studied by fluorescent in situ hybridization on tissue sections and/or conventional karyotyping on bone marrow or peripheral blood. Histologically, 50% of the tumors were of the blastic type, 43.5% either monoblastic or myelomonocytic and 6.5% corresponded to different histotypes. CD68/KP1 was the most commonly expressed marker (100%), followed by myeloperoxidase (83.6%), CD117 (80.4%), CD99 (54.3%), CD68/PG-M1 (51%)…

AdultGenetic MarkersMaleCancer ResearchPathologymedicine.medical_specialtyAdolescentLymphomaCD34BiologyTrisomy 8Translocation Geneticcytogeneticsmyeloid sarcoma; chloroma; FISH; cytogenetics; immunohistochemistry; prognosisFISHAntigens CDmyeloid sarcomamedicineMyeloid sarcomaHumansIn Situ Hybridization FluorescenceAgedAged 80 and overChromosome Aberrationsmedicine.diagnostic_testCytogeneticschloromaSarcomaHematologyMiddle Agedmedicine.diseaseTransplantationLeukemiaPhenotypeOncologyLeukemia MyeloidimmunohistochemistryFemaleprognosisSarcomaalpha interferonCD30 antigenCD34 antigenFluorescence in situ hybridization
researchProduct

Transient CD15-positive endothelial phenotype in the human placenta correlates with physiological and pathological fetoplacental immaturity

2013

Abstract Objective Placental growth and villous maturation are critical parameters of placental function at the end of pregnancy. A failure in these processes leads to the development of placental dysfunction, as well as fetal and neonatal mortality and morbidity. The aim of the study was to determine the relevant diagnostic markers associated with pathological placental development. Study design Forty tissue samples from normal placentas of different gestational age and 68 pathological term placentas with defective villous maturation (GDM, idiopathic IUFD, preeclamsia, HELLP syndrome) comprised the comparative immunohistochemical study (CD15, CD45 and CD34). Positive immunohistochemical re…

AdultHELLP SyndromePathologymedicine.medical_specialtyStromal cellEndotheliumHELLP syndromePlacentaCD34Lewis X AntigenAntigens CD34Gestational AgePre-EclampsiaPregnancymedicineHumansPathologicalPregnancyFetusFetal Growth Retardationbusiness.industryEndothelial CellsObstetrics and GynecologyFucosyltransferasesmedicine.diseaseImmunohistochemistryPlacentationDiabetes Gestationalmedicine.anatomical_structureReproductive MedicineCase-Control Studiesembryonic structuresLeukocyte Common AntigensImmunohistochemistryFemalebusinessEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
researchProduct